Efficacy and safety from this phase IV study were consistent with data from the Vabysmo phase III DME studies
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
Data demonstrate the importance of protecting against serious respiratory infections caused by respiratory syncytial virus, human metapneumovirus and COVID-19
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
The market size of Aspart in India is currently estimated over Rs. 260 crore with only 2 players
The first phase of the Aptivate Achi Bhookh Fest reached over 8,200 households
Enhertu demonstrated clinically meaningful efficacy in previously treated patients
GBM affects nearly 13,000 patients annually in the US and approximately 300,000 globally
Declan brings over 25 years of expertise in the pharmaceutical and biotech sectors
India has been declared ‘functional’ against all the core regulatory functions of the WHO Global Benchmarking Tool Version VI
Subscribe To Our Newsletter & Stay Updated
